Drug Profile
FK 633
Alternative Names: FR 144633Latest Information Update: 02 Oct 2001
Price :
$50
*
At a glance
- Originator Fujisawa
- Class Antiplatelets; Small molecules; Vascular disorder therapies
- Mechanism of Action GPIIb-IIIa antagonists; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary artery restenosis; Thrombosis
Most Recent Events
- 02 Oct 2001 No-Development-Reported for Coronary artery restenosis in Japan (Unknown route)
- 02 Oct 2001 No-Development-Reported for Thrombosis in Japan (IV)
- 05 Aug 1999 Phase-II clinical trials for Thrombosis in Japan (IV)